Answers are grounded in this paper and cite their sources.
Sirolimus appears to be effective and safe in patients with life-threatening vascular anomalies and represents an important tool in treating these diseases. These findings are currently being further evaluated in a Phase II safety and efficacy trial.
No takes yet. Share an insight, caveat, or question.
Hammill et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: